New Research Reveals Type 1 Diabetes in Adults May Not Be One Single Disease

Type 1 diabetes has long been viewed as a single autoimmune disease with a predictable course. But researchers have noticed that adults diagnosed with Type 1 diabetes don't always follow the same pattern. Some lose beta-cell function rapidly; others decline more slowly. Some develop complications quickly; others don't. These differences have puzzled doctors and scientists for years.

A new study from Germany set out to answer a fundamental question: Are these differences just variations of the same disease, or are they actually distinct subtypes that might need different approaches?

Researchers analyzed data from 600 adults in the German Diabetes Study who had been recently diagnosed with Type 1 diabetes. They also included adults who were originally diagnosed with Type 2 diabetes but who tested positive for GADA (glutamic acid decarboxylase antibodies), an immune marker of Type 1 diabetes.

Using machine learning—a computational method that finds patterns in complex data—the team grouped people based on immune markers, blood sugar, cholesterol levels, and genetic risk factors. They then tracked these groups over an average of six years to see how their disease progressed, how much beta-cell function they retained, and what complications they developed.

The findings were also tested in a separate registry of adults with Type 1 diabetes to confirm the results held true in another population.

The analysis identified at least three distinct subtypes of Type 1 diabetes in adults. Each subtype had different genetic backgrounds, different patterns of autoimmune activity, different levels of remaining insulin-producing capacity, and different metabolic profiles involving blood sugar, cholesterol, and triglycerides.

This means that two people both diagnosed with 'Type 1 diabetes' might actually have different underlying disease processes. Their immune systems may be attacking the pancreas in different ways. Their remaining beta cells may function differently. And their genetic risk factors—both for Type 1 and Type 2 diabetes—may differ significantly.

If these subtypes are confirmed in future research, they could change how doctors understand and manage Type 1 diabetes in adults. Knowing which subtype someone has might eventually help predict how quickly their beta cells will fail, which complications they're at higher risk for, and whether certain treatments would be more effective for them.

This research is still in early stages. The subtypes have been identified and documented, but much more work is needed to understand exactly what drives each one, how to reliably identify which subtype a person has at diagnosis, and how to use this information to improve outcomes. Researchers are continuing to follow these cohorts to gather more evidence.

This study is observational—it describes patterns in data but does not prove that these subtypes require different treatments. The findings come from European populations and may not fully apply to other ethnic or geographic groups. More research is needed before subtype classification becomes a standard part of Type 1 diabetes diagnosis or care.

Source: The lancet. Diabetes & endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.